Leave your contact details and we will contact you
The cost of services is determined by their scope and content and is calculated upon request via email at info@rncph.ru
Home
Analytical databases
We produce accurate analytical tools
RNC Pharma provides partners with a wide range of syndicated projects on
the analyzed markets
Contact us
Contact us
About project
We provide 24/7 remote access from any part of the world through an intuitive and clear online interface
User access allows to construct reports of the required structure and upload them to users' devices in a table format (xlsx or csv). Clients have the access to a flexible system of user settings, including advanced search and filtering features, customizing and saving your own templates. RNC Pharma specialists provide the training for new users and operational support to customers when it is needed
Retail sales audit
This block of projects allows us to analyze operational processes that take place in the retail segment of the Russian pharmaceutical and related markets in order to conduct competitive analysis, monitor the effectiveness of marketing activities, evaluate the distribution levels of specific products, commodity neighborhood, size of the average check, etc.
Production of pharmaceuticals in Russia
The project allows estimating the actual output of specific products, including the launch of new drugs that have not entered the distribution system yet. It tracks import substitution trends, estimates the amount of actual demand for
active pharmaceutical ingredients, auxiliary substances and packaging materials
11.08.2026
In Q1–Q2 2026, the Russian retail market for botulinum toxins exceeded RUB 10.3 billion.
06.08.2026
In recent years, the Russian veterinary retail market has seen steady double-digit growth in demand for drugs used to treat cardiovascular diseases.
04.08.2026
In the first half of 2026, total sales of breast pumps on the Russian retail market exceeded 379.9 thousand units, which in monetary terms amounted to RUB 755.4 million.
30.07.2026
In June 2026, the Russian retail pharmaceutical market showed a redistribution of demand for drugs between megacities and tourist regions, characteristic of the summer season.
29.07.2026
Since 2023, sales of specific drugs for the treatment of leprosy (EphMRA group J04B) have been growing rapidly in our country.
28.07.2026
In the first half of 2026, the Russian retail market for antiallergic ophthalmic drugs showed signs of slowing sales growth.
27.07.2026
In the first half of 2026, Russians purchased 27.1 million packages of topical wound-healing drugs worth RUB 9.4 billion.
23.07.2026
In the first half of 2026, the total retail sales volume of medical thermometers of all types on the Russian market amounted to 4.9 million units, equivalent to RUB 1.6 billion in monetary terms.